-
1
-
-
84873120585
-
Primary sclerosing cholangitis: A review and update on therapeutic developments
-
Tabibian JH, Lindor KD. Primary sclerosing cholangitis: A review and update on therapeutic developments. Expert Rev Gastroenterol Hepatol 2013;7:103-14.
-
(2013)
Expert Rev Gastroenterol Hepatol
, vol.7
, pp. 103-114
-
-
Tabibian, J.H.1
Lindor, K.D.2
-
2
-
-
84860856008
-
Primary sclerosing cholangitis: Etiopathogenesis and clinical management
-
Gupta A, Bowlus CL. Primary sclerosing cholangitis: Etiopathogenesis and clinical management. Front Biosci 2012;4: 1683-705.
-
(2012)
Front Biosci
, vol.4
, pp. 1683-1705
-
-
Gupta, A.1
Bowlus, C.L.2
-
3
-
-
84887422384
-
Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis
-
Tabibian JH, Lindor KD. Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis. J Anal Oncol 2012;1:50-5.
-
(2012)
J Anal Oncol
, vol.1
, pp. 50-55
-
-
Tabibian, J.H.1
Lindor, K.D.2
-
4
-
-
40849123925
-
The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy
-
Weismuller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 2008;48:S38-57.
-
(2008)
J Hepatol
, vol.48
-
-
Weismuller, T.J.1
Wedemeyer, J.2
Kubicka, S.3
Strassburg, C.P.4
Manns, M.P.5
-
6
-
-
84892141612
-
Malignancies in patients with inflammatory bowel disease: anationwideregister study in Finland
-
Jussila A, Virta LJ, Pukkala E, Farkkila MA. Malignancies in patientswithinflammatoryboweldisease:anationwideregister study in Finland. Scand J Gastroenterol 2013;48:1405-13.
-
(2013)
Scand J Gastroenterol
, vol.48
, pp. 1405-1413
-
-
Jussila, A.1
Virta, L.J.2
Pukkala, E.3
Farkkila, M.A.4
-
7
-
-
75449104123
-
Diagnosis and management of primary sclerosing cholangitis
-
Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660-78.
-
(2010)
Hepatology
, vol.51
, pp. 660-678
-
-
Chapman, R.1
Fevery, J.2
Kalloo, A.3
Nagorney, D.M.4
Boberg, K.M.5
Shneider, B.6
-
8
-
-
67649232094
-
A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts
-
Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 2009;15:330-40.
-
(2009)
Liver Transpl
, vol.15
, pp. 330-340
-
-
Alabraba, E.1
Nightingale, P.2
Gunson, B.3
Hubscher, S.4
Olliff, S.5
Mirza, D.6
-
9
-
-
77953472805
-
De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
-
Landaverde C, Ng V, Sato A, Tabibian J, Durazo F, Busuttil R. De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis. Ann Hepatol 2009;8:379-83.
-
(2009)
Ann Hepatol
, vol.8
, pp. 379-383
-
-
Landaverde, C.1
Ng, V.2
Sato, A.3
Tabibian, J.4
Durazo, F.5
Busuttil, R.6
-
10
-
-
67649205149
-
EASL clinical practice guidelines: Management of cholestatic liver diseases
-
Beuers U, Boberg KM, Chapman RW, Chazouillères O, Invernizzi P, Jones DE, et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237-67.
-
(2009)
J Hepatol
, vol.51
, pp. 237-267
-
-
Beuers, U.1
Boberg, K.M.2
Chapman, R.W.3
Chazouillères, O.4
Invernizzi, P.5
Jones, D.E.6
-
11
-
-
10744231617
-
Outcome Following Liver Transplantation for Primary Sclerosing Cholangitis in the Nordic Countries
-
DOI 10.1080/00365520310006009
-
Brandsaeter B, Friman S, Broome U, Isoniemi H, Olausson M, Backman L, et al. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol 2003;38:1176-83. (Pubitemid 37518603)
-
(2003)
Scandinavian Journal of Gastroenterology
, vol.38
, Issue.11
, pp. 1176-1183
-
-
Brandsaeter, B.1
Friman, S.2
Broome, U.3
Isoniemi, H.4
Olausson, M.5
Backman, L.6
Hansen, B.7
Schrumpf, E.8
Oksanen, A.9
Ericzon, B.-G.10
Hockerstedt, K.11
Makisalo, H.12
Kirkegaard, P.13
Bjoro, K.14
-
12
-
-
79958765960
-
Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation
-
Ali JM, Bonomo L, Brais R, Griffiths WJ, Lomas DJ, Huguet EL, et al. Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation. Transplantation 2011;91:1392-7.
-
(2011)
Transplantation
, vol.91
, pp. 1392-1397
-
-
Ali, J.M.1
Bonomo, L.2
Brais, R.3
Griffiths, W.J.4
Lomas, D.J.5
Huguet, E.L.6
-
13
-
-
0038148288
-
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation
-
DOI 10.1053/jlts.2003.50143
-
Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003;9:727-32. (Pubitemid 36874461)
-
(2003)
Liver Transplantation
, vol.9
, Issue.7
, pp. 727-732
-
-
Kugelmas, M.1
Spiegelman, P.2
Osgood, M.J.3
Young, D.A.4
Trotter, J.F.5
Steinberg, T.6
Wachs, M.E.7
Bak, T.8
Kam, I.9
Everson, G.T.10
-
14
-
-
16644377769
-
Increased intestinal permeability in patients with inflammatory bowel disease
-
Welcker K, Martin A, Kolle P, Siebeck M, Gross M. Increased intestinal permeability in patients with inflammatory bowel disease. Eur J Med Res 2004;9:456-60.
-
(2004)
Eur J Med Res
, vol.9
, pp. 456-460
-
-
Welcker, K.1
Martin, A.2
Kolle, P.3
Siebeck, M.4
Gross, M.5
-
15
-
-
33144473772
-
Genetic basis for increased intestinal permeability in families with Crohn's disease: Role of CARD15 3020insC mutation?
-
DOI 10.1136/gut.2005.065557
-
Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, et al. Genetic basis for increased intestinal permeability in families with Crohns disease: role of CARD15 3020insC mutation? Gut 2006;55:342-7. (Pubitemid 43268271)
-
(2006)
Gut
, vol.55
, Issue.3
, pp. 342-347
-
-
Buhner, S.1
Buning, C.2
Genschel, J.3
Kling, K.4
Herrmann, D.5
Dignass, A.6
Kuechler, I.7
Krueqer, S.8
Schmidt, H.H.-J.9
Lochs, H.10
-
16
-
-
84874105072
-
The dynamic biliary epithelia: Molecules, pathways, and disease
-
OHara SP, Tabibian JH, Splinter PL, Larusso NF. The dynamic biliary epithelia: molecules, pathways, and disease. J Hepatol 2013;58:575-82.
-
(2013)
J Hepatol
, vol.58
, pp. 575-582
-
-
Ohara, S.P.1
Tabibian, J.H.2
Splinter, P.L.3
Larusso, N.F.4
-
17
-
-
33644617718
-
Etiopathogenesis of primary sclerosing cholangitis
-
OMahony CA, Vierling JM. Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis 2006;26:3-21. (Pubitemid 43320723)
-
(2006)
Seminars in Liver Disease
, vol.26
, Issue.1
, pp. 3-21
-
-
O'Mahony, C.A.1
Vierling, J.M.2
-
18
-
-
24744458143
-
Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis
-
DOI 10.1080/00365520510023288
-
Bjornsson E, Cederborg A, Akvist A, Simren M, Stotzer PO, Bjarnason I. Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2005;40:1090-4. (Pubitemid 41291359)
-
(2005)
Scandinavian Journal of Gastroenterology
, vol.40
, Issue.9
, pp. 1090-1094
-
-
Bjornsson, E.1
Cederborg, A.2
Akvist, A.3
Simren, M.4
Stotzer, P.-O.5
Bjarnason, I.6
-
19
-
-
84874117027
-
Randomised clinical trial: Vancomycin or metronidazole in patients with primary sclerosing cholangitis -A pilot study
-
Tabibian JH, Weeding E, Jorgensen RA, Petz JL, Keach JC, Talwalkar JA, et al. Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis -A pilot study. Aliment Pharmacol Ther 2013;37:604-12.
-
(2013)
Aliment Pharmacol Ther
, vol.37
, pp. 604-612
-
-
Tabibian, J.H.1
Weeding, E.2
Jorgensen, R.A.3
Petz, J.L.4
Keach, J.C.5
Talwalkar, J.A.6
-
20
-
-
80053991368
-
Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis
-
Mueller T, Beutler C, Pico AH, Shibolet O, Pratt DS, Pascher A, et al. Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis. Liver Int 2011;31:1574-88.
-
(2011)
Liver Int
, vol.31
, pp. 1574-1588
-
-
Mueller, T.1
Beutler, C.2
Pico, A.H.3
Shibolet, O.4
Pratt, D.S.5
Pascher, A.6
-
22
-
-
80052230924
-
Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation
-
OHara SP, Splinter PL, Trussoni CE, Gajdos GB, Lineswala PN, LaRusso NF. Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation. J Biol Chem 2011;286:30352-60.
-
(2011)
J Biol Chem
, vol.286
, pp. 30352-30360
-
-
Ohara, S.P.1
Splinter, P.L.2
Trussoni, C.E.3
Gajdos, G.B.4
Lineswala, P.N.5
Larusso, N.F.6
-
23
-
-
33645741989
-
Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways
-
Yokoyama T, Komori A, Nakamura M, Takii Y, Kamihira T, Shimoda S, et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 2006;26:467-76.
-
(2006)
Liver Int
, vol.26
, pp. 467-476
-
-
Yokoyama, T.1
Komori, A.2
Nakamura, M.3
Takii, Y.4
Kamihira, T.5
Shimoda, S.6
-
24
-
-
35348822432
-
Biliary innate immunity and cholangiopathy
-
DOI 10.1111/j.1872-034X.2007.00247.x
-
Harada K, Nakanuma Y. Biliary innate immunity and cholangiopathy. Hepatol Res 2007;37:S430-7. (Pubitemid 47570656)
-
(2007)
Hepatology Research
, vol.37
, Issue.SUPPL. 3
-
-
Harada, K.1
Nakanuma, Y.2
-
25
-
-
0030863290
-
Lipopolysaccharides and beta-glucuronidase activity in choledochal bile in relation to choledocholithiasis
-
Osnes T, Sandstad O, Skar V, Osnes M. Lipopolysaccharides and beta-glucuronidase activity in choledochal bile in relation to choledocholithiasis. Digestion 1997;58:437-43. (Pubitemid 27445611)
-
(1997)
Digestion
, vol.58
, Issue.5
, pp. 437-443
-
-
Osnes, T.1
Sandstad, O.2
Skar, V.3
Osnes, M.4
-
27
-
-
0025801063
-
Biliary tract disease in rats with experimental small bowel bacterial overgrowth
-
Lichtman SN, Keku J, Clark RL, Schwab JH, Sartor RB. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991;13:766-72.
-
(1991)
Hepatology
, vol.13
, pp. 766-772
-
-
Lichtman, S.N.1
Keku, J.2
Clark, R.L.3
Schwab, J.H.4
Sartor, R.B.5
-
28
-
-
0026451945
-
Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth
-
Lichtman SN, Okoruwa EE, Keku J, Schwab JH, Sartor RB. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest 1992;90:1313-22.
-
(1992)
J Clin Invest
, vol.90
, pp. 1313-1322
-
-
Lichtman, S.N.1
Okoruwa, E.E.2
Keku, J.3
Schwab, J.H.4
Sartor, R.B.5
-
29
-
-
0029311525
-
A microcholangiographic study of liver disease models in rats
-
Lichtman SN, Wang J, Clark RL. A microcholangiographic study of liver disease models in rats. Acad Radiol 1995;2: 515-21.
-
(1995)
Acad Radiol
, vol.2
, pp. 515-521
-
-
Lichtman, S.N.1
Wang, J.2
Clark, R.L.3
-
30
-
-
0027935792
-
Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats
-
DOI 10.1007/BF02365447
-
Yamada S, Ishii M, Liang LS, Yamamoto T, Toyota T. Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats. J Gastroenterol 1994;29: 631-6. (Pubitemid 24308414)
-
(1994)
Journal of Gastroenterology
, vol.29
, Issue.5
, pp. 631-636
-
-
Yamada, S.1
Ishii, M.2
Liang, L.S.3
Yamamoto, T.4
Toyota, T.5
-
31
-
-
77950353635
-
Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation
-
Haruta I, Kikuchi K, Hashimoto E, Nakamura M, Miyakawa H, Hirota K, et al. Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest 2010;90: 577-88.
-
(2010)
Lab Invest
, vol.90
, pp. 577-588
-
-
Haruta, I.1
Kikuchi, K.2
Hashimoto, E.3
Nakamura, M.4
Miyakawa, H.5
Hirota, K.6
-
32
-
-
34247196579
-
Biliary Epithelial Cell Antibodies Link Adaptive and Innate Immune Responses in Primary Sclerosing Cholangitis
-
DOI 10.1053/j.gastro.2007.01.039, PII S0016508507001783
-
Karrar A, Broome U, Sodergren T, Jaksch M, Bergquist A, Bjornstedt M, et al. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 2007;132:1504-14. (Pubitemid 46627575)
-
(2007)
Gastroenterology
, vol.132
, Issue.4
, pp. 1504-1514
-
-
Karrar, A.1
Broome, U.2
Sodergren, T.3
Jaksch, M.4
Bergquist, A.5
Bjornstedt, M.6
Sumitran-Holgersson, S.7
-
34
-
-
29344470338
-
The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis
-
DOI 10.1097/00042737-200601000-00012
-
Pohl J, Ring A, Stremmel W, Stiehl A. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2006; 18:69-74. (Pubitemid 43004884)
-
(2006)
European Journal of Gastroenterology and Hepatology
, vol.18
, Issue.1
, pp. 69-74
-
-
Pohl, J.1
Ring, A.2
Stremmel, W.3
Stiehl, A.4
-
35
-
-
0033916878
-
Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis
-
DOI 10.1016/S0168-8278(00)80153-1
-
Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T, et al. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol 2000; 33:9-18. (Pubitemid 30418928)
-
(2000)
Journal of Hepatology
, vol.33
, Issue.1
, pp. 9-18
-
-
Hiramatsu, K.1
Harada, K.2
Tsuneyama, K.3
Sasaki, M.4
Fujita, S.5
Hashimoto, T.6
Kaneko, S.7
Kobayashi, K.8
Nakanuma, Y.9
-
36
-
-
0032032527
-
Bile duct bacterial isolates in primary sclerosing cholangitis: A study of explanted livers
-
DOI 10.1016/S0168-8278(98)80316-4
-
Olsson R, Bjornsson E, Backman L, Friman S, Hockerstedt K, Kaijser B, et al. Bile duct bacterial isolates in primary sclerosing cholangitis: A study of explanted livers. J Hepatol 1998;28:426-32. (Pubitemid 28133546)
-
(1998)
Journal of Hepatology
, vol.28
, Issue.3
, pp. 426-432
-
-
Olsson, R.1
Bjornsson, E.2
Backman, L.3
Friman, S.4
Hockerstedt, K.5
Kaijser, B.6
Olausson, M.7
-
37
-
-
0032171526
-
Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis
-
DOI 10.1016/S0168-8278(98)80058-5
-
Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 1998;29:409-16. (Pubitemid 28396657)
-
(1998)
Journal of Hepatology
, vol.29
, Issue.3
, pp. 409-416
-
-
Sasatomi, K.1
Noguchi, K.2
Sakisaka, S.3
Sata, M.4
Tanikawa, K.5
-
38
-
-
84863981813
-
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
-
Folseraas T, Melum E, Rausch P, Juran BD, Ellinghaus E, Shiryaev A, et al. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol 2012;57:366-75.
-
(2012)
J Hepatol
, vol.57
, pp. 366-375
-
-
Folseraas, T.1
Melum, E.2
Rausch, P.3
Juran, B.D.4
Ellinghaus, E.5
Shiryaev, A.6
-
39
-
-
84878725018
-
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
-
Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 2013;45:670-5.
-
(2013)
Nat Genet
, vol.45
, pp. 670-675
-
-
Liu, J.Z.1
Hov, J.R.2
Folseraas, T.3
Ellinghaus, E.4
Rushbrook, S.M.5
Doncheva, N.T.6
-
40
-
-
77955398591
-
Fucosyltransferase 2 (FUT2) nonsecretor status is associated with Crohns disease
-
McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M, et al. Fucosyltransferase 2 (FUT2) nonsecretor status is associated with Crohns disease. Hum Mol Genet 2010;19:3468-76.
-
(2010)
Hum Mol Genet
, vol.19
, pp. 3468-3476
-
-
McGovern, D.P.1
Jones, M.R.2
Taylor, K.D.3
Marciante, K.4
Yan, X.5
Dubinsky, M.6
-
41
-
-
67649311620
-
Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells
-
Eksteen B, Mora JR, Haughton EL, Henderson NC, Lee-Turner L, Villablanca EJ, et al. Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells. Gastroenterology 2009; 137:320-9.
-
(2009)
Gastroenterology
, vol.137
, pp. 320-329
-
-
Eksteen, B.1
Mora, J.R.2
Haughton, E.L.3
Henderson, N.C.4
Lee-Turner, L.5
Villablanca, E.J.6
-
42
-
-
10644245899
-
Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis
-
DOI 10.1084/jem.20041035
-
Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hubscher SG, et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 2004; 200:1511-17. (Pubitemid 39657298)
-
(2004)
Journal of Experimental Medicine
, vol.200
, Issue.11
, pp. 1511-1517
-
-
Eksteen, B.1
Grant, A.J.2
Miles, A.3
Curbishley, S.M.4
Lalor, P.F.5
Hubscher, S.G.6
Briskin, M.7
Salmon, M.8
Adams, D.H.9
-
43
-
-
70349566408
-
Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis
-
Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol 2009;31:309-22.
-
(2009)
Semin Immunopathol
, vol.31
, pp. 309-322
-
-
Borchers, A.T.1
Shimoda, S.2
Bowlus, C.3
Keen, C.L.4
Gershwin, M.E.5
-
44
-
-
84901634043
-
Cholangiocyte senescence via N-Ras activation is a characteristic of primary sclerosing cholangitis
-
Epub ahead of print
-
Tabibian JH, OHara SP, Splinter PL, Trussoni CE, Larusso NF. Cholangiocyte senescence via N-Ras activation is a characteristic of primary sclerosing cholangitis. Hepatology 2014; Epub ahead of print.
-
(2014)
Hepatology
-
-
Tabibian, J.H.1
Ohara, S.P.2
Splinter, P.L.3
Trussoni, C.E.4
Larusso, N.F.5
-
45
-
-
45449084795
-
Cellular senescence and organismal aging
-
Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev 2008;129:467-74.
-
(2008)
Mech Ageing Dev
, vol.129
, pp. 467-474
-
-
Jeyapalan, J.C.1
Sedivy, J.M.2
-
46
-
-
78349299099
-
Fat tissue, aging, and cellular senescence
-
Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010;9:667-84.
-
(2010)
Aging Cell
, vol.9
, pp. 667-684
-
-
Tchkonia, T.1
Morbeck, D.E.2
Von Zglinicki, T.3
Van Deursen, J.4
Lustgarten, J.5
Scrable, H.6
-
47
-
-
34548186667
-
Cellular senescence: When bad things happen to good cells
-
DOI 10.1038/nrm2233, PII NRM2233
-
Campisi J, dAdda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40. (Pubitemid 47312822)
-
(2007)
Nature Reviews Molecular Cell Biology
, vol.8
, Issue.9
, pp. 729-740
-
-
Campisi, J.1
D'Adda Di Fagagna, F.2
-
48
-
-
60849127227
-
Cellular senescence, ageing and disease
-
Burton DG. Cellular senescence, ageing and disease. Age (Omaha) 2009;31:1-9.
-
(2009)
Age (Omaha)
, vol.31
, pp. 1-9
-
-
Burton, D.G.1
-
49
-
-
84874603171
-
Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities
-
Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J Clin Invest 2013;123:966-72.
-
(2013)
J Clin Invest
, vol.123
, pp. 966-972
-
-
Tchkonia, T.1
Zhu, Y.2
Van Deursen, J.3
Campisi, J.4
Kirkland, J.L.5
-
50
-
-
84891713034
-
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor
-
Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008;6: 2853-68.
-
(2008)
PLoS Biol
, vol.6
, pp. 2853-2868
-
-
Coppe, J.P.1
Patil, C.K.2
Rodier, F.3
Sun, Y.4
Munoz, D.P.5
Goldstein, J.6
-
51
-
-
28244499304
-
Identification of differentially expressed proteins in senescent human embryonic fibroblasts
-
DOI 10.1016/j.mad.2005.08.009, PII S0047637405002071
-
Trougakos IP, Saridaki A, Panayotou G, Gonos ES. Identification of differentially expressed proteins in senescent human embryonic fibroblasts. Mech Ageing Dev 2006; 127:88-92. (Pubitemid 41713520)
-
(2006)
Mechanisms of Ageing and Development
, vol.127
, Issue.1
, pp. 88-92
-
-
Trougakos, I.P.1
Saridaki, A.2
Panayotou, G.3
Gonos, E.S.4
-
52
-
-
44649101304
-
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
-
DOI 10.1016/j.cell.2008.03.039, PII S009286740800620X
-
Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008;133:1019-31. (Pubitemid 351787746)
-
(2008)
Cell
, vol.133
, Issue.6
, pp. 1019-1031
-
-
Kuilman, T.1
Michaloglou, C.2
Vredeveld, L.C.W.3
Douma, S.4
Van Doorn, R.5
Desmet, C.J.6
Aarden, L.A.7
Mooi, W.J.8
Peeper, D.S.9
-
53
-
-
44649120132
-
Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence
-
DOI 10.1016/j.cell.2008.03.038, PII S0092867408006193
-
Acosta JC, OLoghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008;133:1006-18. (Pubitemid 351795610)
-
(2008)
Cell
, vol.133
, Issue.6
, pp. 1006-1018
-
-
Acosta, J.C.1
O'Loghlen, A.2
Banito, A.3
Guijarro, M.V.4
Augert, A.5
Raguz, S.6
Fumagalli, M.7
Da Costa, M.8
Brown, C.9
Popov, N.10
Takatsu, Y.11
Melamed, J.12
D'Adda Di Fagagna, F.13
Bernard, D.14
Hernando, E.15
Gil, J.16
-
54
-
-
84878583731
-
Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, livemouse cholangiography
-
Tabibian JH, Macura SI, OHara SP, Fidler JL, Glockner JF, Takahashi N, et al. Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, livemouse cholangiography. Lab Invest 2013;93:733-43.
-
(2013)
Lab Invest
, vol.93
, pp. 733-743
-
-
Tabibian, J.H.1
Macura, S.I.2
Ohara, S.P.3
Fidler, J.L.4
Glockner, J.F.5
Takahashi, N.6
-
55
-
-
78651227093
-
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
-
Melum E, Franke A, Schramm C, Weismuller TJ, Gotthardt DN, Offner FA, et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 2011;43:17-19.
-
(2011)
Nat Genet
, vol.43
, pp. 17-19
-
-
Melum, E.1
Franke, A.2
Schramm, C.3
Weismuller, T.J.4
Gotthardt, D.N.5
Offner, F.A.6
-
56
-
-
0000072924
-
The liver in ulcerative colitis; Treatment of pericholangitis with tetracycline
-
Rankin JG, Boden RW, Goulston SJ, Morrow W. The liver in ulcerative colitis; treatment of pericholangitis with tetracycline. Lancet 1959;2:1110-12.
-
(1959)
Lancet
, vol.2
, pp. 1110-1112
-
-
Rankin, J.G.1
Boden, R.W.2
Goulston, S.J.3
Morrow, W.4
-
57
-
-
79958051295
-
Antibiotics for the treatment of primary sclerosing cholangitis
-
Elfaki DA, Lindor KD. Antibiotics for the treatment of primary sclerosing cholangitis. Am J Ther 2011;18:261-5.
-
(2011)
Am J Ther
, vol.18
, pp. 261-265
-
-
Elfaki, D.A.1
Lindor, K.D.2
-
58
-
-
10644269919
-
Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial
-
DOI 10.1002/hep.20457
-
Farkkila M, Karvonen AL, Nurmi H, Nuutinen H, Taavitsainen M, Pikkarainen P, et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial. Hepatology 2004; 40:1379-86. (Pubitemid 39657012)
-
(2004)
Hepatology
, vol.40
, Issue.6
, pp. 1379-1386
-
-
Farkkila, M.1
Karvonen, A.-L.2
Nurmi, H.3
Nuutinen, H.4
Taavitsainen, M.5
Pikkarainen, P.6
Karkkainen, P.7
-
59
-
-
60749089231
-
Minocycline in the treatment of patients with primary sclerosing cholangitis: Results of a pilot study
-
Silveira MG, Torok NJ, Gossard AA, Keach JC, Jorgensen RA, Petz JL, et al. Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study. Am J Gastroenterol 2009;104:83-8.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 83-88
-
-
Silveira, M.G.1
Torok, N.J.2
Gossard, A.A.3
Keach, J.C.4
Jorgensen, R.A.5
Petz, J.L.6
-
60
-
-
0013816559
-
Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis
-
Mistilis SP, Skyring AP, Goulston SJ. Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis. Australas Ann Med 1965;14:286-94.
-
(1965)
Australas Ann Med
, vol.14
, pp. 286-294
-
-
Mistilis, S.P.1
Skyring, A.P.2
Goulston, S.J.3
-
61
-
-
0032135138
-
Case report: Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine
-
Kozaiwa K, Tajiri H, Sawada A, Tada K, Etani Y, Miki K, et al. Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine. J Gastroenterol Hepatol 1998;13:825-9. (Pubitemid 28374900)
-
(1998)
Journal of Gastroenterology and Hepatology
, vol.13
, Issue.8
, pp. 825-829
-
-
Kozaiwa, K.1
Tajiri, H.2
Sawada, A.3
Tada, K.4
Etani, Y.5
Miki, K.6
Okada, S.7
-
62
-
-
0031782677
-
Oral vancomycin: Treatment of primary sclerosing cholangitis in children with inflammatory bowel disease
-
DOI 10.1097/00005176-199811000-00015
-
Cox KL, Cox KM. Oral vancomycin: Treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1998;27:580-3. (Pubitemid 28492259)
-
(1998)
Journal of Pediatric Gastroenterology and Nutrition
, vol.27
, Issue.5
, pp. 580-583
-
-
Cox, K.L.1
Cox, K.M.2
-
63
-
-
0036959298
-
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis
-
Broccoletti T CE, Spaziano M, Capuano G, Petrone E, Mandato C, Migliaro F, et al. Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis. Ital J Pediatr 2002;28:515-17. (Pubitemid 36383057)
-
(2002)
Italian Journal of Pediatrics
, vol.28
, Issue.6
, pp. 515-517
-
-
Broccoletti, T.1
Ciccimarra, E.2
Spaziano, M.3
Capuano, G.4
Petrone, E.5
Mandato, C.6
Migliaro, F.7
Vajro, P.8
-
64
-
-
33744801168
-
Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis [1]
-
DOI 10.1007/s00535-005-1758-x
-
Tada S, Ebinuma H, Saito H, Hibi T. Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis. J Gastroenterol 2006;41:388-9. (Pubitemid 43834384)
-
(2006)
Journal of Gastroenterology
, vol.41
, Issue.4
, pp. 388-389
-
-
Tada, S.1
Ebinuma, H.2
Saito, H.3
Hibi, T.4
-
65
-
-
37749028067
-
Azithromycin may reduce cholestasis in primary sclerosing cholangitis: A case report and serendipitous observation
-
Boner AL, Peroni D, Bodini A, Delaini G, Piacentini G. Azithromycin may reduce cholestasis in primary sclerosing cholangitis: A case report and serendipitous observation. Int J Immunopathol Pharmacol 2007;20:847-9.
-
(2007)
Int J Immunopathol Pharmacol
, vol.20
, pp. 847-849
-
-
Boner, A.L.1
Peroni, D.2
Bodini, A.3
Delaini, G.4
Piacentini, G.5
-
66
-
-
55549136784
-
Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic
-
Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic. J Pediatr Gastroenterol Nutr 2008;47:61-7.
-
(2008)
J Pediatr Gastroenterol Nutr
, vol.47
, pp. 61-67
-
-
Davies, Y.K.1
Cox, K.M.2
Abdullah, B.A.3
Safta, A.4
Terry, A.B.5
Cox, K.L.6
-
67
-
-
0020624187
-
Metronidazole in primary cholangitis
-
Mathew KK. Metronidazole in primary cholangitis. J Indian Med Assoc 1983;80:31; 33.
-
(1983)
J Indian Med Assoc
, vol.80
, pp. 31-33
-
-
Mathew, K.K.1
-
68
-
-
84904440489
-
Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin
-
Davies YK, Tsay CJ, Caccamo DV, Cox KM, Castillo RO, Cox KL. Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin. Case Rep Transpl 2013;2013:314292.
-
(2013)
Case Rep Transpl
, vol.2013
, pp. 314292
-
-
Davies, Y.K.1
Tsay, C.J.2
Caccamo, D.V.3
Cox, K.M.4
Castillo, R.O.5
Cox, K.L.6
-
69
-
-
62149093658
-
Probiotics in primary sclerosing cholangitis: A randomized placebocontrolled crossover pilot study
-
Vleggaar FP, Monkelbaan JF, van Erpecum KJ. Probiotics in primary sclerosing cholangitis: A randomized placebocontrolled crossover pilot study. Eur J Gastroenterol Hepatol 2008;20:688-92.
-
(2008)
Eur J Gastroenterol Hepatol
, vol.20
, pp. 688-692
-
-
Vleggaar, F.P.1
Monkelbaan, J.F.2
Van Erpecum, K.J.3
-
70
-
-
84879887023
-
Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis
-
Abarbanel DN, Seki SM, Davies Y, Marlen N, Benavides JA, Cox K, et al. Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis. J Clin Immunol 2013;33: 397-406.
-
(2013)
J Clin Immunol
, vol.33
, pp. 397-406
-
-
Abarbanel, D.N.1
Seki, S.M.2
Davies, Y.3
Marlen, N.4
Benavides, J.A.5
Cox, K.6
|